Log In
BCIQ
Print this Print this
 

PEN-866 (formerly STA-12-8666)

Also known as: HDC SN-38

  Manage Alerts
Collapse Summary General Information
Company Madrigal Pharmaceuticals Inc.
DescriptionHsp90-inhibitor drug conjugate (HDC) composed of an inhibitor of heat shock protein 90 (Hsp90) joined to SN-38 via a cleavable chemical linker
Molecular Target Heat shock protein 90 (Hsp90)
Mechanism of ActionHsp90 inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerTarveda Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$249.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/19/2016

$249.0M

Undisclosed

Undisclosed

Get a free BioCentury trial today